Skip to content
Surgical Oncology

Pancreas Tumor Surgery

About This Department

 
Surgical Oncology

Pancreas tumor surgery removes cancers, cysts and neuroendocrine tumors of the pancreas by Whipple, distal or total pancreatectomy. For pancreatic cancer, treatment before surgery has tripled five-year survival in a Dutch trial.

Where the tumor sits decides the operation. A tumor in the head of the pancreas needs a Whipple operation, one in the body or tail a distal pancreatectomy, and a small neuroendocrine tumor sometimes only its own removal. At Johns Hopkins, hospital mortality across 1,000 consecutive Whipple operations came to 1 percent, and the PREOPANC trial raised five-year survival from 6.5 to 20.5 percent with treatment before surgery. Send your CT or MRI, tumor markers and any biopsy, and our pancreas team will tell you whether the tumor can come out.

1%
Hospital mortality in 1,000 consecutive Whipple operations at Johns Hopkins
20.5% vs 6.5%
Five-year survival, treatment before surgery against surgery first, PREOPANC
61%
Locally advanced cancers made operable after FOLFIRINOX, Heidelberg
Free
Review of your scans before you book
Free consultation

The pancreas lies behind the stomach, with a head tucked into the curve of the duodenum, a body crossing the spine and a tail reaching the spleen. The bile duct runs through the head, so tumors there turn the skin yellow early, while tumors of the body and tail grow silently for longer.

Three main operations
A Whipple operation, pancreaticoduodenectomy, removes the head of the pancreas with the duodenum, the end of the bile duct and the gallbladder. A distal pancreatectomy removes the body and tail, covered on our distal pancreatectomy page. A total pancreatectomy removes the whole gland and leaves lifelong diabetes, so we keep it for tumors running through the entire pancreas.

Which pancreas tumors need surgery

Every adenocarcinoma that can come out with clear margins, most neuroendocrine tumors above 2 cm, and cysts with worrying features. A tumor wrapped around the main arteries cannot come out at first, and chemotherapy decides whether it later can.

Folfirinox is a valuable treatment option in the neoadjuvant therapy of PDAC.
Heidelberg series of 575 patients, Annals of Surgery, 2016

Cysts and IPMN

When a cyst needs surgery
Most pancreatic cysts never become cancer, and the international Fukuoka guidelines favor watching most branch-duct IPMNs with MRI. Jaundice from a cyst in the head, a solid part that lights up on scans, or a main pancreatic duct of 10 mm or wider marks a high-risk cyst for removal. Main-duct IPMN and mucinous cystic neoplasms in fit patients come out.

Tumor types and operations

The tumor type sets both the operation and the treatment around it.

This table scrolls sideways on a narrow screen. Swipe or drag to see every column.

Pancreas tumors and their usual operation
Tumor Behavior Usual operation
Adenocarcinoma Aggressive cancer, the commonest type Whipple or distal pancreatectomy with chemotherapy
Neuroendocrine tumor Slow growing, some make hormones Enucleation, Whipple or distal pancreatectomy
IPMN or mucinous cyst Benign at first, can turn to cancer Resection when high-risk features appear
Solid pseudopapillary tumor Low grade, young women Resection, cured in nearly all

The Whipple operation

Over five to seven hours, the surgeon removes the head of the pancreas, the duodenum, the end of the bile duct and the gallbladder, then rebuilds the route with three joins, pancreas to bowel, bile duct to bowel and stomach to bowel.

Experience matters
Gooiker and colleagues pooled 14 good-quality studies of pancreatic surgery. High-volume hospitals cut the odds of death after surgery by two thirds and the risk of death over the following years by a fifth, while the volume of an individual surgeon showed no significant effect on its own.
There was a consistent association between high hospital volume and lower postoperative mortality rates with improved long-term survival.
Meta-analysis of 14 studies, British Journal of Surgery, 2011

This table scrolls sideways on a narrow screen. Swipe or drag to see every column.

One thousand consecutive Whipple operations at Johns Hopkins, 1969 to 2003
Measure Result
Hospital mortality 1 percent
Median hospital stay 17 days in the 1980s, 9 days in the 2000s
Median operating time 8.8 hours in the 1970s, 5.5 hours in the 2000s
Five-year survival, pancreatic cancer 18 percent overall, 32 percent with clear lymph nodes, 41 percent with clear nodes and margins
It has become an effective operation for pancreatic cancer in those patients in whom their tumor is margin negative and node negative.
Johns Hopkins series of 1,000 operations, Annals of Surgery, 2006

Keeping the stomach outlet

The pylorus-preserving Whipple keeps the whole stomach and its outlet valve. A Cochrane review of six trials with 465 patients found the same mortality, complications and survival as the classic operation, with a shorter operating time, so we choose by where the tumor lies.

No evidence suggests relevant differences in mortality, morbidity and survival between the two operations.
Cochrane review of six randomized trials, 2014

Chemotherapy before surgery

Pancreatic cancer spreads early, in many patients before scans can see it. Treating the whole body first, before the operation, deals with that hidden spread. In the Dutch PREOPANC trial of 246 patients, chemoradiotherapy before surgery raised five-year survival from 6.5 to 20.5 percent, though median survival differed by only 1.4 months, which shows the gain came from a group of long-term survivors.


Neoadjuvant gemcitabine-based chemoradiotherapy followed by surgery and adjuvant gemcitabine improves OS compared with upfront surgery and adjuvant gemcitabine in resectable and borderline resectable pancreatic cancer.
PREOPANC trial, Journal of Clinical Oncology, 2022

Locally advanced tumors

A tumor wrapped around the main arteries counts as locally advanced. Chemotherapy comes first, and surgery follows only when the cancer has held still or shrunk.


Chemotherapy
FOLFIRINOX for four to six months in fit patients.
Restaging
CT, tumor markers and a tumor board review.
Exploration
An operation to check whether the tumor has come free of the vessels.
Resection
Removal of the tumor, sometimes with a segment of vein rebuilt during the same operation.

This table scrolls sideways on a narrow screen. Swipe or drag to see every column.

Heidelberg series, surgery after treatment for locally advanced pancreatic cancer, 575 patients
Outcome Result
Resection after FOLFIRINOX 61 percent
Resection after gemcitabine with radiotherapy 46 percent
Median survival after resection 15.3 months
Median survival after exploration alone 8.5 months
What these numbers mean
Six in ten patients treated with FOLFIRINOX reached a resection in Heidelberg, and four did not. Three-year survival after resection reached 28 percent in the FOLFIRINOX group. These patients came from one experienced center, and an exploration that ends without resection still carries the recovery of an abdominal operation.

Results, risks and recovery

  • A leak from the pancreatic join.
  • Slow stomach emptying after a Whipple.
  • Bleeding, early or weeks later.
  • A bile leak.
  • New diabetes and a need for digestive enzymes.

This table scrolls sideways on a narrow screen. Swipe or drag to see every column.

PREOPANC, treatment before surgery against surgery first, 246 patients
Outcome Treatment first Surgery first
Survival at five years 20.5 percent 6.5 percent
Median survival 15.7 months 14.3 months

Days one to three
Intensive care or a high-dependency bed, then walking and sips of water.
Days four to ten
Eating again, drains tested and removed, discharge between day seven and day twelve after a Whipple.
Weeks two to eight
Enzyme capsules with meals, weight checks, building strength.
Within twelve weeks
Chemotherapy after surgery for cancer.
Enzymes and blood sugar
Pancreatic enzyme capsules with every meal replace the digestive juice the removed tissue made, and blood sugar checks pick up new diabetes. Patients with diabetes before surgery need closer control afterwards.

Neuroendocrine tumors


Enucleation

A small neuroendocrine tumor at the surface of the pancreas shells out alone. The gland stays intact. This works only when the tumor sits a few millimeters or more from the main pancreatic duct, since a duct injury during enucleation leaks pancreatic juice for weeks, and when scans show no spread to lymph nodes, which would call for a formal resection with node removal instead. Tumors under 2 cm that make no hormones and stay still on scans go to surveillance.


The stay in Istanbul

Planning the trip
Plan two to three weeks in Istanbul after a Whipple and ten to fourteen days after a smaller operation. Our surgeon confirms fitness to fly once you eat well and the drains are out. A companion can sleep in your room. Our coordinators speak English, Arabic, French, Russian, Serbian, Romanian and Spanish, and follow-up after you return home runs through them, with the pathology report and the chemotherapy plan sent to your oncologist. The cost depends on the operation, any chemotherapy given here and the length of stay, and the estimate after the free review lists each.

What to send for review

Four items.

A complete set saves weeks
Our tumor board decides on surgery, chemotherapy first or surveillance from these, before you book a flight.
  1. A pancreas protocol CT or MRI under four weeks old.
  2. CA 19-9 and CEA blood tests, with bilirubin.
  3. Endoscopic ultrasound and biopsy reports.
  4. Details of any stent and chemotherapy so far.

Pancreas tumor surgery FAQ

Is pancreatic tumor surgery dangerous?
It carries real risk. In experienced hands, hospital mortality after a Whipple came to 1 percent in a series of 1,000 operations.
Can pancreatic cancer be cured by surgery?
For some patients. Five-year survival reached 41 percent after a Whipple with clear lymph nodes and margins at Johns Hopkins.
Do I need chemotherapy before surgery?
For many pancreatic cancers, yes. The PREOPANC trial tripled five-year survival with treatment first.
Do all pancreatic cysts need surgery?
No. Most need only MRI surveillance, and cysts with high-risk features come out.
Will I get diabetes after pancreas surgery?
Some patients do, more after larger resections and with diabetes risk beforehand. A total pancreatectomy always causes it.

References

  1. Cameron JL, Riall TS, Coleman J, Belcher KA. One thousand consecutive pancreaticoduodenectomies. Annals of Surgery. 2006;244(1):10-15.
  2. Versteijne E, van Dam JL, Suker M, et al. Neoadjuvant chemoradiotherapy versus upfront surgery for resectable and borderline resectable pancreatic cancer: long-term results of the Dutch randomized PREOPANC trial. Journal of Clinical Oncology. 2022;40(11):1220-1230.
  3. Hackert T, Sachsenmaier M, Hinz U, et al. Locally advanced pancreatic cancer: neoadjuvant therapy with Folfirinox results in resectability in 60% of the patients. Annals of Surgery. 2016;264(3):457-463.
  4. Gooiker GA, van Gijn W, Wouters MW, et al. Systematic review and meta-analysis of the volume-outcome relationship in pancreatic surgery. British Journal of Surgery. 2011;98(4):485-494.
  5. Diener MK, Fitzmaurice C, Schwarzer G, et al. Pylorus-preserving pancreaticoduodenectomy (pp Whipple) versus pancreaticoduodenectomy (classic Whipple) for surgical treatment of periampullary and pancreatic carcinoma. Cochrane Database of Systematic Reviews. 2014;2014(11):CD006053.

Editor's note

Written by the Biruni Hospital medical editorial team. Reviewed by Prof. Dr. Metin GÜDEN, Radiation Oncology.

Last updated:

Related Treatments

View All